Women’s Health Diagnostics Market: Increase in Awareness among People about the Availability of Treatments for Sexually Transmitted Diseases to Drive the Market

Wilmington, Delaware, United States, Transparency Market Research Inc. – Women’s health diagnostics are used to analyze and detect health issues in women such as breast cancer, cervical cancer, fertility & pregnancy testing, and infectious disease testing.

The women’s health diagnostics market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the women’s health diagnostics market with respect to segments based on device type, test type, end user, and region

The overview section of the report analyzes the market dynamics and trends, such as drivers, restraints, and opportunities that influence the women’s health diagnostics market. The section also covers market revenue projections, market attractiveness analysis, and key market share analysis in order to provide a thorough analysis of the overall competitive scenario in the women’s health diagnostics market.

Request Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=63339

 

Women’s Health Diagnostics Market: Key Drivers

The women’s health diagnostics market is driven by menopause, increase in awareness among people about the availability of treatments for sexually transmitted diseases, surge in women health awareness, favorable incentive and reimbursement policies for UTIs, and increase in diseases in women

According to the Society of Obstetricians & Gynecologists of Canada, around 80% women claim to suffer from, at least, one menopausal symptom including mood swings, irritability, interrupted sleep, hot flushes, and vaginal dryness

However, risk of breast cancer with HRT treatment, increase in demand for alternative therapies, and legal obligations are the major factors anticipated to restrain the global market

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=63339

Market Segmentation: Women’s Health Diagnostics Market

In terms of device type, the women’s health diagnostics market has been classified into biopsy devices, imaging & monitoring systems, kits & reagents, and consumables & accessories. The kits & reagents segment held a major share of the global market in 2018, as kits & reagents are used in tests such as cancer biopsy, prenatal genetic testing, and infectious disease testing.

Based on test type, the women’s health diagnostics market has been categorized into breast cancer testing, cervical cancer testing, prenatal genetic screening & carrier testing, pregnancy testing, fertility & ovulation testing, infectious disease testing, and others. The infectious disease testing segment dominated the market in 2018, owing to high incidence of infectious diseases in women.

Request for Report Methodology - https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=63339

In terms of end user, the women’s health diagnostics market has been divided into hospitals, diagnostic laboratories & imaging centers, specialty clinics, and others. The diagnostic laboratories & imaging centers segment accounted for a significant share of the market in 2018. The segment is expected to retain its leadership position during the forecast period. Growth of the segment can be attributed to increase in the number of diagnostic procedures in diagnostic laboratories & imaging centers.

Each of the segments of the women’s health diagnostics market has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The report provides current and future revenues (US$ Mn) for each of these segments for the period from 2017 to 2027, considering 2018 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2019 to 2027, along with market size estimations.

Ask for References - https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=63339

Regional Overview: Women’s Health Diagnostics Market

In terms of region, the global women’s health diagnostics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a significant share of the global market in 2018. The market in the region is anticipated to be driven by high rate of adoption of women’s health diagnostics for women’s disease analysis.

The study also offers a list of recommendations, highlights, and useful insights of the market, which would help new companies willing to enter the market, and existing companies to increase market shares and help in the decision-making process

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=63339

Major Players in Global Market

The women’s health diagnostics report concludes with the company profiles section that includes key information about the major players in the market

Key players operating in the global women’s health diagnostics market include

  • Abbott Laboratories
  • Becton
  • Dickinson and Company
  • bioMérieux SA
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • Quest Diagnostics Inc.
  • Cardinal Health
  • Siemens AG

More Trending Reports by Transparency Market Research –

Retinal Vein Occlusion Market: The retinal vein occlusion market is slated to clock a favorable CAGR of 7.3% during the forecast period.

Adrenocorticotropic Hormone Market: The global adrenocorticotropic hormone (ACTH) market was valued at US$ 1.3 Bn in 2020 and is anticipated to expand at a CAGR of 3.9% from 2021 to 2031.

Veterinary Supplements Market: The veterinary supplements market is anticipated to expand at a CAGR of 6.5% during the forecast period.

Von Willebrand Disease Treatment Market: The global von Willebrand disease treatment market is expected to attain a market value of ~US$ 900 Mn by the end of 2030.

Rare Neurodegenerative Disease Treatment Market: The global rare neurodegenerative disease treatment market is expected to attain a market value of US$ 116.3 Bn by the end of 2030.

Dry Eye Disease Diagnostics & Treatment Market: The global dry eye disease diagnostics & treatment market is on the course to reach US$ 9.8 Bn by the end of 2030.

Topical Antibiotics Market: The global topical antibiotics market is anticipated to attain a market value of US$ 8.3 Bn by the end of 2030.

In-vitro Inflammatory Bowel Disease Diagnostic Market: The global in-vitro inflammatory bowel disease diagnostics market is expected to expand at a CAGR of ~4% during the forecast period.

About Us

 

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

 

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

 

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

 

The women’s health diagnostics market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the women’s health diagnostics market with respect to segments based on device type, test type, end user, and region

The overview section of the report analyzes the market dynamics and trends, such as drivers, restraints, and opportunities that influence the women’s health diagnostics market. The section also covers market revenue projections, market attractiveness analysis, and key market share analysis in order to provide a thorough analysis of the overall competitive scenario in the women’s health diagnostics market.

Request Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=63339

 

Women’s Health Diagnostics Market: Key Drivers

The women’s health diagnostics market is driven by menopause, increase in awareness among people about the availability of treatments for sexually transmitted diseases, surge in women health awareness, favorable incentive and reimbursement policies for UTIs, and increase in diseases in women

According to the Society of Obstetricians & Gynecologists of Canada, around 80% women claim to suffer from, at least, one menopausal symptom including mood swings, irritability, interrupted sleep, hot flushes, and vaginal dryness

However, risk of breast cancer with HRT treatment, increase in demand for alternative therapies, and legal obligations are the major factors anticipated to restrain the global market

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=63339

Market Segmentation: Women’s Health Diagnostics Market

In terms of device type, the women’s health diagnostics market has been classified into biopsy devices, imaging & monitoring systems, kits & reagents, and consumables & accessories. The kits & reagents segment held a major share of the global market in 2018, as kits & reagents are used in tests such as cancer biopsy, prenatal genetic testing, and infectious disease testing.

Based on test type, the women’s health diagnostics market has been categorized into breast cancer testing, cervical cancer testing, prenatal genetic screening & carrier testing, pregnancy testing, fertility & ovulation testing, infectious disease testing, and others. The infectious disease testing segment dominated the market in 2018, owing to high incidence of infectious diseases in women.

Request for Report Methodology - https://www.transparencymarketresearch.com/sample/sample.php?flag=RRM&rep_id=63339

In terms of end user, the women’s health diagnostics market has been divided into hospitals, diagnostic laboratories & imaging centers, specialty clinics, and others. The diagnostic laboratories & imaging centers segment accounted for a significant share of the market in 2018. The segment is expected to retain its leadership position during the forecast period. Growth of the segment can be attributed to increase in the number of diagnostic procedures in diagnostic laboratories & imaging centers.

Each of the segments of the women’s health diagnostics market has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights. The report provides current and future revenues (US$ Mn) for each of these segments for the period from 2017 to 2027, considering 2018 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2019 to 2027, along with market size estimations.

Ask for References - https://www.transparencymarketresearch.com/sample/sample.php?flag=ARF&rep_id=63339

Regional Overview: Women’s Health Diagnostics Market

In terms of region, the global women’s health diagnostics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a significant share of the global market in 2018. The market in the region is anticipated to be driven by high rate of adoption of women’s health diagnostics for women’s disease analysis.

The study also offers a list of recommendations, highlights, and useful insights of the market, which would help new companies willing to enter the market, and existing companies to increase market shares and help in the decision-making process

Make an Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=63339

Major Players in Global Market

The women’s health diagnostics report concludes with the company profiles section that includes key information about the major players in the market

Key players operating in the global women’s health diagnostics market include

  • Abbott Laboratories
  • Becton
  • Dickinson and Company
  • bioMérieux SA
  • F. Hoffmann-La Roche AG
  • GE Healthcare
  • Hologic, Inc.
  • Koninklijke Philips N.V.
  • Quest Diagnostics Inc.
  • Cardinal Health
  • Siemens AG

More Trending Reports by Transparency Market Research –

Retinal Vein Occlusion Market: The retinal vein occlusion market is slated to clock a favorable CAGR of 7.3% during the forecast period.

Adrenocorticotropic Hormone Market: The global adrenocorticotropic hormone (ACTH) market was valued at US$ 1.3 Bn in 2020 and is anticipated to expand at a CAGR of 3.9% from 2021 to 2031.

Veterinary Supplements Market: The veterinary supplements market is anticipated to expand at a CAGR of 6.5% during the forecast period.

Von Willebrand Disease Treatment Market: The global von Willebrand disease treatment market is expected to attain a market value of ~US$ 900 Mn by the end of 2030.

Rare Neurodegenerative Disease Treatment Market: The global rare neurodegenerative disease treatment market is expected to attain a market value of US$ 116.3 Bn by the end of 2030.

Dry Eye Disease Diagnostics & Treatment Market: The global dry eye disease diagnostics & treatment market is on the course to reach US$ 9.8 Bn by the end of 2030.

Topical Antibiotics Market: The global topical antibiotics market is anticipated to attain a market value of US$ 8.3 Bn by the end of 2030.

In-vitro Inflammatory Bowel Disease Diagnostic Market: The global in-vitro inflammatory bowel disease diagnostics market is expected to expand at a CAGR of ~4% during the forecast period.

About Us

 

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyze information.

 

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

 

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Blog: https://tmrblog.com
Email: sales@transparencymarketresearch.com

 

Back to news